CLINICAL_TRIALS
trial_result
· 2023-02-21
Clinical Trial Update: Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan [Phase 2]
Summary
Phase 2 trial comparing different doses of rostafuroxin to losartan for antihypertensive effects has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Windtree Therapeutics | Conditions: Hypertension | Phase 2 | Status: COMPLETED